David Patience - 14 Aug 2025 Form 4 Insider Report for TriSalus Life Sciences, Inc. (TLSI)

Signature
/s/ David Patience
Issuer symbol
TLSI
Transactions as of
14 Aug 2025
Net transactions value
$0
Form type
4
Filing time
15 Aug 2025, 17:29:18 UTC
Previous filing
10 Jul 2025
Next filing
29 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Patience David Chief Financial Officer 6272 W. 91ST AVENUE, WESTMINSTER /s/ David Patience 15 Aug 2025 0001970009

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLSI Common Stock Award $0 +200,000 $0.000000 200,000 14 Aug 2025 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLSI Employee Stock Option (right to buy) Award $0 +290,000 $0.000000 290,000 14 Aug 2025 Common Stock 290,000 $3.88 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents grant of restricted stock units (the "RSU Award") payable solely in common stock of the Issuer. The shares subject to the RSU Award vest in four equal annual installments commencing on July 1, 2026, subject to the Reporting Person's continued service with the Issuer on each respective vesting date.
F2 One-fourth (1/4th) of the shares subject to the option shall vest on the one-year anniversary of the vesting commencement date of July 1, 2026 (the "VCD"), and 1/36th of the remaining shares shall vest each month thereafter on the same day of the month as the VCD (or if there is no corresponding day, on the last day of the month), subject to the Reporting Person's continuous service with the Issuer on each respective vesting date.